Non-invasive ocular drug delivery
Research Unit: Drug Delivery
Primary Supervisor: Dr Hong Zhang
Tel: +613 9288 3721/ Email: email@example.com
Our research focuses on non-invasive and targeted tools, treatment options and technologies for vision threatening diseases such as endophthalmitis, age-related macular degeneration, glaucoma and diabetic retinopathy. Novel methods such as ocular implant, ultrasound and nanotechnology will be performed. Results from these novel therapeutic studies will be evaluated using histological, immunohistochemical and molecular biological techniques. The information gained from these studies is directly applicable to the clinical setting. Students will be involved in the establishment and optimisation of ocular drug delivery protocols and performing in vitro and in vivo verification studies of these methods; they will also be able to participate in ongoing projects.